Communiqués GeneThera, Inc.

Actions

GTHR

US37185E3062

Marché Fermé - OTC Markets Autres places de cotation 19:14:13 20/02/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-99,98%		-.--%	-.--%

2022	GeneThera, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2022	CI
2022	GeneThera, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2022	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

GENETHERA INC - 10-K/A -	01/02/23	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14/11/22	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	18/08/22	AQ
GENETHERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	18/05/22	AQ
GENETHERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	14/04/22	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/11/21	AQ
GeneThera : Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project	12/10/21	GL
GENETHERA INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	12/10/21	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/08/21	AQ
GeneThera : Expands Its Operation in the United Kingdom	18/05/21	AQ
GENETHERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	12/05/21	AQ
GeneThera : enters into a collaboration agreement with an International Construction Advisor Company to build a network of zoonotic diseases laboratory facilities	27/04/21	AQ
GENETHERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	14/04/21	AQ
GeneThera : Strategy for the Development of a Global Zoonotic Diseases Surveillance System Using Smart Testing Technology	13/04/21	AQ
GeneThera Technology Platform for Wastewater Testing: A More Effective Way to Control the COVID-19 Pandemic	06/04/21	AQ
GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic	30/03/21	AQ
GENETHERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)	18/11/20	AQ
GENETHERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/11/20	AQ
GENETHERA : 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	21/09/20	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)	10/09/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués GeneThera, Inc.

Actions

GTHR

US37185E3062

Communiqués

Filtres